MSCompany report
Morgan Stanley MS
The bet you're really making is that Morgan Stanley has quietly turned into a money-management machine that earns steady fees from millions of wealthy clients whether or not markets are hot. You're betting that wealth business keeps growing and keeps the profit coming even when deal-making and trading go quiet, which they always eventually do. Right now it is going well, with one thing to watch: the last two quarters were the highest profits in at least five years, up about 62% from a year earlier, but much of that lift rode a hot markets tape that will cool. You pay about 18 times last year's earnings, near the top of what the stock has fetched in twelve years, and about what rivals cost.
Key data
MS · price with moving averages
Source: market data.
The business
Morgan Stanley is two firms bolted together. One is a wealth and investment management operation that holds and invests money for wealthy households and institutions and charges a fee on the balance every year, a fee that arrives whether the market rises or falls. The other is an investment bank, the old Morgan Stanley, that trades stocks and bonds for big institutions and advises companies on mergers and share sales, a business that booms and busts with the appetite for deals. Over the last decade the firm deliberately shifted its weight toward the first: the E*Trade and Eaton Vance deals were bought precisely to widen that recurring fee base. The reason the stock re-rated is that investors began paying for a fee machine instead of a trading house. What a client actually holds is an account statement with an advisory-fee line on it, a few tenths of a percent skimmed each year, invisible and automatic. That fee is the moat. Once a household's money and its financial life sit inside the platform, it rarely leaves.
The numbers
The profit line tells this better than any revenue figure, because for a broker the reported top line is muddied by interest gross-ups.
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q2 2025 | $28.2B | $3.54B | $2.13 |
| Q3 2025 | $30.0B | $4.61B | $2.80 |
| Q4 2025 | $28.9B | $4.40B | $2.67 |
| Q1 2026 | $33.1B | $5.64B | $3.40 |
| Q2 2026 | $34.5B | $5.58B | $3.41 |
The two most recent quarters are the highest in at least five years, and the record-profit run the last look flagged did not break, it extended, with June edging past March back to back. June EPS of $3.46 was up 62% on a year earlier.
| Period | Net income, $B | Diluted EPS |
|---|---|---|
| FY2021 | 15.03 | 8.03 |
| FY2022 | 11.03 | 6.15 |
| FY2023 | 9.09 | 5.18 |
| FY2024 | 13.39 | 7.95 |
| FY2025 | 16.86 | 10.21 |
| 2026, 1H to June | 11.15 | 6.89 |
The dip is visible: profit fell from $15.0B in 2021 to $9.1B in 2023 as deal-making froze, recovered to a record $16.9B in 2025, and the first half of 2026 already carries $11.1B, up 42% on the same half last year. That is the inflection, and it is not subtle.
| Quarter | EPS actual | EPS est | Surprise |
|---|---|---|---|
| Q3 2025 | 2.80 | 2.10 | +33% |
| Q4 2025 | 2.68 | 2.43 | +10% |
| Q1 2026 | 3.43 | 3.02 | +14% |
| Q2 2026 | 3.46 | 2.89 | +20% |
Four straight beats, averaging about 19%, is the tell that the trading and banking tape ran hot, and the honest reading is that some of this profit is cyclical and will not repeat at this rate. EPS went from $5.18 in 2023 to $10.21 in 2025, nearly a double in two years, but consensus sees only $13.67 for 2027 and $14.79 for 2028, about 8% a year off a high base. The variant this memo holds: the market still prices MS as half-cyclical and treats the rebound as temporary. If the wealth fee base holds return on equity near 18% through a slow-deal year, the multiple re-rates rather than the earnings, and the print that settles it is a soft-markets quarter where fees carry the profit.
Management
Insiders have been sellers, not buyers: zero open-market purchases against $51.7M sold across 33 transactions in twelve months, the largest a $6.3M sale by Andrew Saperstein in April and a $6.0M sale by Dan Simkowitz in January. None carry a disclosed 10b5-1 footnote in this feed, so plan status is not disclosed, and for a firm that pays its seniors heavily in stock, routine selling into a strong tape is the least informative signal on the board. What matters more is what the pay rewards, return on tangible equity, and that figure sitting near 18% is why the stock holds a premium multiple. The balance sheet has expanded fast alongside the profits, which is the one thing the clean earnings story explains least well.
How it fails or surprises you
The wealth flywheel re-rates it (right tail). If fee-based client assets keep compounding and the recurring line carries profit through a slow deal year, the market stops pricing MS as a cyclical broker. A single soft-markets quarter where earnings hold near $3 a share would do more for the multiple than any boom quarter. The Street still discounts durability it is not paying for.
The tape cools and the beats reverse. Four straight beats near 19% rode hot trading and M&A. A volatility collapse or a deal drought cuts the institutional line fast, and the print is the next quarter's EPS landing at or below consensus instead of well above it. At the top of its twelve-year range, MS has no multiple cushion for a miss.
The balance sheet grows faster than the story admits. Long-term debt climbed from $284B to $383B in eighteen months, up 35%, and cash rose to $160B. For a broker that is normal funding, but the pace, against volatile and often negative operating cash flow, is the fact the durable-machine read explains least. Watch the next 10-Q's debt and liquidity lines.
Closing thoughts
This is mostly a stock the market has already figured out. At 17.6 times trailing earnings and 15.9 times next year's, near the top of a twelve-year range and right on the peer multiple, MS is priced as a good business having a good year, not as a mispriced one. The edge, if there is one, sits on the other side of a question the price does not resolve: is the wealth fee base durable enough to deserve a permanently higher multiple, or is a third of this profit a cyclical trading rebound that fades? The person selling to you is exiting at the ceiling on the bet the tape cools first; you would be buying the bet that fees hold the line when it does. The nearer, fatter tail is the downside one, a flow slowdown compressing a full-priced multiple, because that resolves in a quarter or two while the re-rate takes years of proof.
The bet is still that Morgan Stanley has turned into a money-management machine earning steady fees from millions of wealthy clients whether or not markets are hot, and that the wealth business keeps growing and keeps the profit coming when deal-making and trading go quiet. What breaks it is a cooling markets tape arriving before the fee base is big enough to cover, and the one pair of numbers that tells you first is next quarter's EPS against consensus alongside the trading revenue line: hold the beat and the durability case is intact, miss it and you learn how much of this was the cycle.
Methodology
The year-to-date row is the sum of the 2 reported quarters of the current fiscal year, diluted EPS included; the five-quarter and five-year tables are the vendor income statements.
Net income and diluted EPS are as-filed from the 10-Q filed Aug 4, 2026 (period ended June 30, 2026) and prior filings; Q4 2025 is derived as full-year 2025 less the first nine months, and the 2026 1H row sums the two filed quarters and is labeled a half, not a year.
Revenue is deliberately not shown: for a broker the vendor gross-revenue line is inflated by interest gross-ups, so the top-line trend is read through profit and EPS.
Trailing P/E uses TTM diluted EPS of $12.37 through Q2 2026; forward P/E uses FY2027 consensus EPS of $13.67; the multiple's position within a 2014-2025 P/E history is stated as judgment.
Insider figures are twelve-month open-market activity; no 10b5-1 plan status is disclosed in this feed, so sales are not split into scheduled versus discretionary.
Price, the 52-week range and price-to-book are vendor market data as of Sep 6, 2026; return on equity near 18% is a vendor TTM figure. Documentation prepared with AI assistance. Not investment advice.
Fact check: bundle financials reconciled to FMP and filed XBRL; all numerical claims verified against 10-Q filed 2026-08-04. Executive title "co-president" for Saperstein removed (not independently verified). 0 numerical errors. Verified Sep 6, 2026.
Bid Cap
Daily ideas, a 390-name database, and a model long/short book from an investor who mostly covers financials. $70 a month or $700 a year.
Subscribe on Substack


